FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2214582728> ?p ?o ?g. }

• W2214582728 abstract "Background: The benefit of oral antiplatelet therapy following PCI is well established. Dual antiplatelet therapy is guideline recommended treatment for one year following a PCI. Objective: To examine discontinuation and adherence rates of oral anti-platelet therapy of patients with acute coronary syndrome (ACS) in the year following a PCI. Methods: From the HealthCore Integrated Research Environment, patients ≥18 years old and hospitalized for ACS (inpatient hospitalization with a primary diagnosis for acute myocardial infarction or unstable angina) during 8/1/09-6/30/13 (index hospitalization) were identified and followed up to 12 months. Patients with an OAP prescription fill within 6 months prior to the index hospitalization, those with a fill for ticagrelor at any time during the study period, those simultaneously starting clopidogrel and prasugrel following the index hospitalization, and those who had a coronary artery bypass graft during index hospitalization were excluded. OAP prescription utilization patterns were examined drug class (clopidogrel or prasugrel) as a whole and by branded versus generic clopidogrel. Medication adherence to OAP therapy was assessed as discontinuation (a period of >45 days not covered by supply of OAP therapy) and the proportion of days covered (PDC; calculated as total day supply during the follow-up divided by days from first fill to end of follow-up). Results: Of 38,626 ACS patients identified, 20,753 were revascularized with PCI during the index hospitalization, and 17,237 (83.1%) went on to fill an OAP prescription (12,714 with clopidogrel as first OAP treatment; 4,523 with prasugrel). On average, patients filled OAP medication 6.7 days following index hospitalization discharge (71% filled on discharge date). The study also found that 20% of patients discontinued OAP therapy during follow-up and 86% of follow-up days were covered by an OAP therapy supply on average. Other medication classes within the same patients had higher discontinuation rates and lower PDC: anti-hypertensive (27% discontinuation; 82% PDC), anti-diabetics (27%; 83%) statins (27%; 82%), and beta-blockers (37%; 72%). Discontinuation rates were considerably lower in patients taking generic clopidogrel versus those filling branded drug (11% for generic vs. 37% for branded) and PDC was higher for generic clopidogrel (90% PDC vs. 75% for branded). Conclusions: Adherence to OAP therapy compares favorably to adherence rates of other cardiovascular/metabolic medications taken by the same patients. Lower out of pocket costs were also associated with better refill compliance. The above findings present healthcare providers with an opportunity to further improve on medication adherence post-PCI in ACS patients by reducing the economic burden on patients." @default.
• W2214582728 created "2016-06-24" @default.
• W2214582728 creator A5003895261 @default.
• W2214582728 creator A5033636078 @default.
• W2214582728 creator A5041701077 @default.
• W2214582728 creator A5050501626 @default.
• W2214582728 date "2014-07-01" @default.
• W2214582728 modified "2023-09-23" @default.
• W2214582728 title "Abstract 164: Adherence to Oral Antiplatelet (OAP) Therapy among ACS Patients Undergoing Percutaneous Coronary Intervention (PCI)" @default.
• W2214582728 doi "https://doi.org/10.1161/circoutcomes.7.suppl_1.164" @default.
• W2214582728 hasPublicationYear "2014" @default.
• W2214582728 type Work @default.
• W2214582728 sameAs 2214582728 @default.
• W2214582728 citedByCount "0" @default.
• W2214582728 crossrefType "journal-article" @default.
• W2214582728 hasAuthorship W2214582728A5003895261 @default.
• W2214582728 hasAuthorship W2214582728A5033636078 @default.
• W2214582728 hasAuthorship W2214582728A5041701077 @default.
• W2214582728 hasAuthorship W2214582728A5050501626 @default.
• W2214582728 hasConcept C126322002 @default.
• W2214582728 hasConcept C164705383 @default.
• W2214582728 hasConcept C2777028646 @default.
• W2214582728 hasConcept C2777628954 @default.
• W2214582728 hasConcept C2777698277 @default.
• W2214582728 hasConcept C2777849778 @default.
• W2214582728 hasConcept C2778715236 @default.
• W2214582728 hasConcept C2780400711 @default.
• W2214582728 hasConcept C2780890252 @default.
• W2214582728 hasConcept C45393284 @default.
• W2214582728 hasConcept C500558357 @default.
• W2214582728 hasConcept C71924100 @default.
• W2214582728 hasConceptScore W2214582728C126322002 @default.
• W2214582728 hasConceptScore W2214582728C164705383 @default.
• W2214582728 hasConceptScore W2214582728C2777028646 @default.
• W2214582728 hasConceptScore W2214582728C2777628954 @default.
• W2214582728 hasConceptScore W2214582728C2777698277 @default.
• W2214582728 hasConceptScore W2214582728C2777849778 @default.
• W2214582728 hasConceptScore W2214582728C2778715236 @default.
• W2214582728 hasConceptScore W2214582728C2780400711 @default.
• W2214582728 hasConceptScore W2214582728C2780890252 @default.
• W2214582728 hasConceptScore W2214582728C45393284 @default.
• W2214582728 hasConceptScore W2214582728C500558357 @default.
• W2214582728 hasConceptScore W2214582728C71924100 @default.
• W2214582728 hasIssue "suppl_1" @default.
• W2214582728 hasLocation W22145827281 @default.
• W2214582728 hasOpenAccess W2214582728 @default.
• W2214582728 hasPrimaryLocation W22145827281 @default.
• W2214582728 hasRelatedWork W1972242685 @default.
• W2214582728 hasRelatedWork W2006720193 @default.
• W2214582728 hasRelatedWork W2020938793 @default.
• W2214582728 hasRelatedWork W2027057839 @default.
• W2214582728 hasRelatedWork W2093585593 @default.
• W2214582728 hasRelatedWork W2094155489 @default.
• W2214582728 hasRelatedWork W2107972557 @default.
• W2214582728 hasRelatedWork W2163907653 @default.
• W2214582728 hasRelatedWork W2201293541 @default.
• W2214582728 hasRelatedWork W2211953154 @default.
• W2214582728 hasRelatedWork W2288055917 @default.
• W2214582728 hasRelatedWork W2302769053 @default.
• W2214582728 hasRelatedWork W2407916448 @default.
• W2214582728 hasRelatedWork W2462854799 @default.
• W2214582728 hasRelatedWork W2519201368 @default.
• W2214582728 hasRelatedWork W2626064924 @default.
• W2214582728 hasRelatedWork W2626932805 @default.
• W2214582728 hasRelatedWork W2734183257 @default.
• W2214582728 hasRelatedWork W2795120429 @default.
• W2214582728 hasRelatedWork W3025721985 @default.
• W2214582728 hasVolume "7" @default.
• W2214582728 isParatext "false" @default.
• W2214582728 isRetracted "false" @default.
• W2214582728 magId "2214582728" @default.
• W2214582728 workType "article" @default.